HealthTech

Chinese biotech firm Changchun, US-based Yarrow sign $1.4b deal

Published

1 month ago

December 16, 2025

Startup Story Media

[ad_1]

Biopharma
Health Care
Investment

By StartupStory | December 16, 2025

Chinese biopharmaceutical company Changchun High-Tech Industry Group has entered a licensing agreement worth up to $1.4 billion with US-based Yarrow Bioscience for an innovative…

[ad_2]

Source link